Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review

doi:10.4239/wjd.v13.i1.5

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 1

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11432)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

766

WORD

226

HTML

7459

Figures (1-3)

354

Tables (1-2)

379

Sum=9184

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

343

Download

608

Sum=951

Publishing Process of This Article

Item

Count

Browse

442

Download

855

Sum=1297

Jan 15, 2022 (publication date) through Dec 1, 2024

Times Cited of This Article

Times Cited (34)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Jan 15, 2022; 13(1): 5-26
Published online Jan 15, 2022. doi: 10.4239/wjd.v13.i1.5

Full Size Figure Download Figure

Figure 3 The interaction of positive (green arrow) and negative (red arrow) factors affecting dysglycemia in women with polycystic ovary syndrome. T2D: Type 2 diabetes mellitus; GLP-1: Glucagon-like peptide 1.

Citation: Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes 2022; 13(1): 5-26
URL: https://www.wjgnet.com/1948-9358/full/v13/i1/5.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i1.5